Vanda Pharmaceuticals (VNDA) Change in Cash (2016 - 2025)
Vanda Pharmaceuticals' Change in Cash history spans 16 years, with the latest figure at $14.8 million for Q4 2025.
- On a quarterly basis, Change in Cash rose 715.23% to $14.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$17.5 million, a 47.87% increase, with the full-year FY2025 number at -$17.5 million, up 47.87% from a year prior.
- Change in Cash hit $14.8 million in Q4 2025 for Vanda Pharmaceuticals, up from -$11.0 million in the prior quarter.
- Over the last five years, Change in Cash for VNDA hit a ceiling of $219.1 million in Q1 2023 and a floor of -$204.1 million in Q2 2023.
- Historically, Change in Cash has averaged $1.2 million across 5 years, with a median of -$4.6 million in 2021.
- Biggest five-year swings in Change in Cash: skyrocketed 5428.21% in 2022 and later plummeted 2245.63% in 2023.
- Tracing VNDA's Change in Cash over 5 years: stood at $1.5 million in 2021, then skyrocketed by 5428.21% to $85.6 million in 2022, then tumbled by 155.31% to -$47.4 million in 2023, then surged by 103.84% to $1.8 million in 2024, then surged by 715.23% to $14.8 million in 2025.
- Business Quant data shows Change in Cash for VNDA at $14.8 million in Q4 2025, -$11.0 million in Q3 2025, and -$30.8 million in Q2 2025.